Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 28, 2012. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. The only financial metrics disclosed relate to the share buyback transaction and capital structure:
- Shares Purchased: 1,300,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,464.5 pence per share; lowest price paid was 1,445.0 pence per share.
- Treasury Holdings (Settled): 494,658,927 shares, representing 9.04% of total issued share capital.
- Treasury Holdings (Including Unsettled): 498,408,927 shares, representing 10.01% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,977,479,327 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,300,000 shares on August 28, 2012. This transaction increased the company's treasury share holdings to over 10% of total voting rights when including unsettled purchases.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Services Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer to purchase or subscribe for securities.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (494,658,927 settled) against the company's latest capitalization table.
- Confirm the percentage of total voting rights held in Treasury (10.01% including unsettled) for disclosure threshold calculations.
- Check the average price paid per share (between 1,445.0 and 1,464.5 pence) against market prices on August 28, 2012.
- Review the total issued share capital excluding treasury shares (4,977,479,327) for accurate EPS and voting right calculations.